$KITE News Options remain limited for growth-stock

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
$KITE News

Options remain limited for growth-stock speculators 3:17 p.m. Jan. 22, 2015 - The Trading Deck
Some of the Nasdaq’s leading lights have begun to dim 2:03 p.m. Jan. 15, 2015 - The Trading Deck
Leading growth stocks continue to shine 3:08 p.m. Jan. 13, 2015 - The Trading Deck
6 stocks to watch 9:22 a.m. Jan. 8, 2015 - The Trading Deck
Amgen and Kite Pharma in cancer immunotherapy pact 10:01 a.m. Jan. 5, 2015 - Tess Stynes
S&P 500 ends higher for first-ever close above 2,000 3:32 p.m. Aug. 26, 2014 - Victor Reklaitis
Google buys Zync; Mobileye rallies, Orbitz falls 2:34 p.m. Aug. 26, 2014 - Angela Johnson
Kite Pharma shares fly high on study results 4:47 p.m. Aug. 25, 2014 - Wallace Witkowski
Kite Pharma shares surge 49% on drug study result 3:50 p.m. Aug. 25, 2014 - Wallace Witkowski

Advaxis: Legit Reasons to Take Another Look at Under-Appreciated Cancer Immunotherapy 9:53 a.m. Jan. 27, 2015 - TheStreet.com
Can CAR-T Therapy Live Up To The Biotech IPO Hype? 7:02 a.m. Jan. 26, 2015 - Investors Business Daily
Kite Pharma (KITE) in Focus: Stock Tumbles 9.2% - Tale of the Tape 8:56 a.m. Jan. 22, 2015 - Zacks.com
CAR-T Vs ErbB3 Market Opportunity Comparison 1:32 p.m. Jan. 21, 2015 - Seeking Alpha
Advaxis: Heavily Promoted And Misleading Investors 9:30 a.m. Jan. 21, 2015 - Seeking Alpha
Why Wynn Resorts, SAP and Kite Pharma Are 3 of Today’s Worst Stocks 10:49 a.m. Jan. 20, 2015 - InvestorPlace.com
8 Biotech Stock Controversies Emerging From 'JPM15' Conference 10:18 a.m. Jan. 20, 2015 - TheStreet.com
The Week That Was: Healthcare Outlook Remains Excellent 9:44 a.m. Jan. 20, 2015 - Seeking Alpha
Investments for the Long Term 8:38 p.m. Jan. 17, 2015 - The Wall Street Journal Interactive Edition
ZIOPHARM, Intrexon Ink CAR T Deal with MD Anderson - Analyst Blog 4:45 p.m. Jan. 16, 2015 - Zacks.com
Kite Pharma/Amgen: A Strong Combination 1:19 p.m. Jan. 15, 2015 - Seeking Alpha
Ziopharm up big on CAR-T license deal 8:25 a.m. Jan. 14, 2015 - Seeking Alpha
Value Investing Strategy For Biotech 12:57 p.m. Jan. 12, 2015 - Seeking Alpha
Seeking Alpha's Biotech Weekly: Gilead Rises With Phenex, Bass's Patent Attack, And More 4:00 p.m. Jan. 9, 2015 - Seeking Alpha
Mizuho Securities Initiates Kite Pharma With Buy 7:40 a.m. Jan. 9, 2015 - benzinga.com
I-Bankers Look At Another Huge Year for IPOs 8:30 a.m. Jan. 8, 2015 - InvestorPlace.com
Kite Pharma inks deal with NIH in HPV-related cancer 1:28 p.m. Jan. 7, 2015 - Seeking Alpha
Pharmaceutical Companies Amgen and Kite Partner for Cancer Therapy 12:18 p.m. Jan. 7, 2015 - GuruFocus.com
Biotech Stock Roundup: Kite Flies High on Amgen Deal, Isis Soars on J&J Collaboration - Analyst Blog 9:09 a.m. Jan. 7, 2015 - Zacks.com
Kite Pharma Up on Amgen Cancer Immunotherapy Tie-Up - Analyst Blog 7:00 p.m. Jan. 6, 2015 - Zacks.com


Kite Pharma Announces Expanded Agreement with Tel Aviv Sourasky Medical Center and Pioneering Researcher Professor Zelig Eshhar to Develop Novel Chimeric Antigen Receptor (CAR) Approaches for Cancer Immunotherapy 8:01 a.m. Jan. 22, 2015 - GlobeNewswire
Kite Pharma Announces Presentations Highlighting Cancer Immunotherapy T Cell Manufacturing Process 3:00 p.m. Jan. 19, 2015 - GlobeNewswire
Today's Review on Biotech Equities - Kite Pharma, Organovo Holdings, BioMarin Pharma, NephroGenex, and Neuralstem 9:15 a.m. Jan. 9, 2015 - PR Newswire - PRF
Kite Pharma Expands Senior Management Team With Appointment of Claudine Prowse, Ph.D., as SVP, Corporate Communications and Investor Relations 8:01 a.m. Jan. 9, 2015 - GlobeNewswire
Kite Pharma Announces Addition of Scott N. Bernstein as Vice President of Intellectual Property Law 5:14 p.m. Jan. 8, 2015 - GlobeNewswire
Kite Pharma Announces Exclusive License With the National Institutes of Health for T Cell Receptor (TCR)-Based Products to Treat HPV-Associated Cancers 1:00 p.m. Jan. 7, 2015 - GlobeNewswire
Kite Pharma to Present at the 33rd Annual J.P. Morgan Healthcare Conference 8:01 a.m. Jan. 7, 2015 - GlobeNewswire
Scaling New Heights: Complimentary Research on Stereotaxis, Kite Pharma, ISIS Pharma, Merck and General Motors 8:50 a.m. Jan. 6, 2015 - PR Newswire - PRF
Kite Pharma Granted Orphan Drug Designation in the European Union for KTE-C19, Kite's Lead Anti-CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy 8:01 a.m. Jan. 6, 2015 - GlobeNewswire
Amgen and Kite Pharma Announce Strategic Cancer Immunotherapy Collaboration to Advance the Application of Novel Chimeric Antigen Receptor (CAR) T Cell Therapies 9:00 a.m. Jan. 5, 2015 - PR Newswire - PRF
Kite Pharma Announces Full Exercise of Underwriters' Option to Purchase Additional Shares 8:31 a.m. Dec. 30, 2014 - GlobeNewswire
Kite Pharma Submits Investigational New Drug Application for Phase 1/2 Trial of KTE-C19, Anti-CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy, for the Treatment of Refractory Aggressive Non-Hodgkin Lymphoma 12:40 p.m. Dec. 22, 2014 - GlobeNewswire
Kite Pharma Added to the NASDAQ Biotechnology Index 8:01 a.m. Dec. 16, 2014 - GlobeNewswire
Annual Changes to the NASDAQ Biotechnology Index 7:10 a.m. Dec. 15, 2014 - GlobeNewswire
Kite Pharma Announces Pricing of Follow-On Offering 9:00 p.m. Dec. 10, 2014 - GlobeNewswire
BioPharm Insight Releases Hematological Cancer Report in Advance of American Society of Hematology (ASH) Annual Meeting Next Month 2:19 p.m. Nov. 24, 2014 - BusinessWire - BZX
Kite Pharma Announces Presentations at the Upcoming 56th American Society of Hematology Annual Meeting 8:01 a.m. Nov. 18, 2014 - GlobeNewswire
Could This Emerging Drug Developer Really Be Worth A Billion Dollars In Five Years? 8:02 a.m. Nov. 17, 2014 - ACCESSWIRE
Kite Pharma Receives Positive Opinion for Orphan Drug Designation in the European Union for KTE-C19, Kite's Lead Investigational Cancer Immunotherapy 8:01 a.m. Nov. 17, 2014 - GlobeNewswire
Kite Pharma Reports Third Quarter 2014 Results 3:20 p.m. Nov. 14, 2014 - GlobeNewswire

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Omega Point's MCP Secures Anthropic Verification

Updated Category News Views 10

In a world where investment decisions ride on razor-thin margins, Omega Point's MCP gains top-tier verification. Anthropic's seal of approval is stamped firmly on it, signalling to the wise investors out there that this engine ain't smoking mirrors. Since May, this player has been doing the rounds, but now, with Anthropic’s verification, it’s like Omega Point just...

Continue Reading
AI-Powered Travel Transformation in Norway Revealed

Updated Category News Views 15

AI-Driven Travel Meets Norway's Authentic Charm Well, folks, once again we're staring down the barrel of technology going full throttle in the travel game. Mindtrip, the savvy AI-powered travel platform, just inked a deal with the Norwegian Travel Cluster. It's their first tango in Europe, and they're not dipping their toes—they're diving headfirst into the icy fjords....

Continue Reading
Jaguar Promise Tackles College Cost for Texas Students

Updated Category News Views 9

Transforming Aspirations into Achievements In the heart of San Antonio, something’s cooking at A&M University-San Antonio, and it's not just the classic breakfast tacos. They've hit a record-breaking enrollment of 7,697 students this Fall, with 1,322 being fresh-faced first-timers. And while that might grab your attention, the real headliner is their Jaguar Promise...

Continue Reading
Marshall Goldman Expands Footprint with Marino Acquisition

Updated Category News Views 13

Revving Up in Florida: Marshall Goldman's Strategic Leap If you're tuned into the luxury car scene, you probably already heard Marshall Goldman is making moves into Florida. Buying Marino Performance Motors of West Palm Beach isn't just another notch on their belt—it's a strategic leap into their second-largest market. This ain't merely about showroom floor space. Think...

Continue Reading
Puori Protein Transparency Pays Off Amid Lead Scare

Updated Category News Views 6

Puori's Moment of Reckoning The world of nutritional supplements is no stranger to controversy, but when Puori found itself caught in the storm of the Consumer Reports investigation last year, it chose a road less traveled: transparency and accountability. Faced with alarming news that over two-thirds of tested protein powders exceeded California's Proposition 65 lead...

Continue Reading
Oracle Announces AI-Driven QuickStart Platform Launch

Updated Category News Views 15

NetSuite's AI-First Step into the Market Well, here's the NYSE stirring the pot with Oracle NetSuite's fresh announcement—an AI-first platform called QuickStart. Sounds like they've got their sights set on early-stage tech startups, banking on those little guys to plug into AI tools they've already got in their toolkit. Claude, ChatGPT—these aren't new kids on the...

Continue Reading
Vayo Debuts as Booking Holdings Eyes $100M Investment

Updated Category News Views 6

A travel revolution might just be on the horizon, courtesy of Booking Holdings' latest venture, Vayo. And they’re talking about throwing $100 million into it—subject to a few conditions, sure—but that’s not pocket change you toss around without a serious plan. Transforming Travel into a Seamless Experience Vayo’s got one job: making your travels less like a...

Continue Reading
Wagner Logistics Gears Up for Major Expansion in Liberty

Updated Category News Views 10

Imagine waking up to news like this: Wagner Logistics is laying down some serious roots in Liberty, MO. They’ve snagged a deal with a local manufacturer that’s got them renting out over 830,000 square feet of warehouse space. Seems Wagner's got a knack for living large. More Than Just a Warehouse Gig Wagner's not just popping up another dusty shelf space; they're...

Continue Reading
WIN Expands Leadership Amidst Rapid Growth Surge

Updated Category News Views 11

Why WIN's Leadership Shake-Up Matters Change is afoot at the fertility and family support powerhouse WIN, and there's no mistaking the bold handwriting on the wall. As they swell towards supporting one million families, WIN's revamping their leadership table with three key players aimed at pushing the envelope further than before. They've got Claudio Stefan, Stacey...

Continue Reading
FCS Drives Key FDA Approvals in Cancer Treatment

Updated Category News Views 12

Florida Cancer Specialists: Changing the Cancer Treatment Game Some organizations toot their horns, but every now and then, a group truly shakes up the playing field. Take Florida Cancer Specialists & Research Institute (FCS), for instance. Over years of relentless research, FCS has nailed its role in securing two significant FDA approvals aimed at expanding treatment...

Continue Reading

Top 5 Most Recently Viewed Articles

Stock Update: Reckitt Benckiser Group Faces Class Action Suit

Updated Category News Views 197

Reckitt Benckiser Group Plc Faces Class Action Lawsuit Pomerantz LLP has announced the initiation of a class action lawsuit against Reckitt Benckiser Group Plc (NASDAQ: RBGLY). This legal action aims to address concerns surrounding the company's potential involvement in securities fraud and various unlawful business practices. If you are an investor affected by Reckitt's...

Continue Reading
Greenbrier to Discuss Fiscal Results in Upcoming Webcast

Updated Category News Views 208

Greenbrier Companies, Inc. Plans Financial Results Conference Call The Greenbrier Companies, Inc. (NYSE: GBX) is set to share significant updates regarding its financial performance for the latest quarter. The company plans to announce its results during a conference call scheduled for a date after the market closes. This engaging session will not only reveal financial...

Continue Reading
Market Gains as Tech Stocks Rally Before Apple's Major Event

Updated Category News Views 168

U.S. Stock Futures Show Positive Momentum As the trading day begins, U.S. stock futures are showing a positive trend following advancements made in the previous session. Investors are optimistic as futures for major indices like the S&P 500 and Nasdaq 100 are moving upward, setting a hopeful tone for the day ahead. Anticipation Build-Up Around Apple Inc. One of the main...

Continue Reading
GDS Holdings Prepares to Share Q3 Financial Results Soon

Updated Category News Views 142

GDS Holdings to Announce Third Quarter 2025 Financial Results SHANGHAI, China – GDS Holdings Limited (“GDS Holdings”, “GDS” or the “Company”) (NASDAQ: GDS; HKEX: 9698) is a prominent developer and operator of high-performance data centers in China. Anticipated for November 19, 2025, GDS will release its unaudited financial results for the third quarter of...

Continue Reading
Valmet Adjusts 2024 EBITA Guidance Amid Market Challenges

Updated Category News Views 136

Valmet Adjusts 2024 EBITA Guidance Amid Market Challenges Valmet Oyj has recently announced an adjustment to its Comparable EBITA guidance for 2024. This update follows observations of slower-than-anticipated market developments, particularly within the EMEA region, as well as in other global markets. Current Market Insights The services market has shown slower growth in...

Continue Reading